Rosenberg Aaron 4

What Happened

Aaron Rosenberg, Chief Financial Officer of BeOne Medicines Ltd. (ONC), received awards of performance share units on 2026-03-06 totaling 119,587 underlying ordinary shares. The awards were reported as two grants: 79,014 shares and 40,573 shares, each recorded at $0.00 (no cash paid), total reported value $0. These were awards (Form 4 transaction code A), not open-market purchases or sales.

Key Details

• Transaction date: 2026-03-06; Form 4 filed 2026-03-10 (within standard reporting window).
• Grant details and prices: 79,014 PSU @ $0.00 and 40,573 PSU @ $0.00; combined = 119,587 PSUs; total reported cash value $0.
• Shares owned following transaction: not specified in the provided filing excerpt.
• Footnotes:
  • F1: 79,014 PSUs will vest in 2027, subject to continued service; unvested securities may accelerate on certain termination events.
  • F2: 40,573 PSUs will vest in 2028, subject to continued service; similar accelerated vesting conditions may apply.
• Transaction code: A = Award/Grant (not a sale or purchase).

Context

Performance share units (PSUs) are conditional awards that convert to ordinary shares only if vesting and any performance conditions are met; these grants do not involve immediate cash exchange or open-market trading. Such awards are typically compensation/retention tools and do not by themselves indicate the insider buying or selling stock for investment reasons.